CTLA4 and Sepsis: Treatment with anti-CTLA4 antibody attenuates T cell apoptosis and improves survival in CLP induced sepsis (using a dose of 50 μg per mouse) and in a two-hit model of CLP induced sepsis followed by fungal infection with C. albicans (using a dose of 50 μg per mouse) (37, 38).